Regulation of Mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia

J Neurosci. 2009 May 27;29(21):7003-14. doi: 10.1523/JNEUROSCI.1110-09.2009.

Abstract

Cerebral ischemia and reperfusion increase superoxide anions (O(2)(*-)) in brain mitochondria. Manganese superoxide dismutase (Mn-SOD; SOD2), a primary mitochondrial antioxidant enzyme, scavenges superoxide radicals and its overexpression provides neuroprotection. However, the regulatory mechanism of Mn-SOD expression during cerebral ischemia and reperfusion is still unclear. In this study, we identified the signal transducer and activator of transcription 3 (STAT3) as a transcription factor of the mouse Mn-SOD gene, and elucidated the mechanism of O(2)(*-) overproduction after transient focal cerebral ischemia (tFCI). We found that Mn-SOD expression is significantly reduced by reperfusion in the cerebral ischemic brain. We also found that activated STAT3 is usually recruited into the mouse Mn-SOD promoter and upregulates transcription of the mouse Mn-SOD gene in the normal brain. However, at early postreperfusion periods after tFCI, STAT3 was rapidly downregulated, and its recruitment into the Mn-SOD promoter was completely blocked. In addition, transcriptional activity of the mouse Mn-SOD gene was significantly reduced by STAT3 inhibition in primary cortical neurons. Moreover, we found that STAT3 deactivated by reperfusion induces accumulation of O(2)(*-) in mitochondria. The loss of STAT3 activity induced neuronal cell death by reducing Mn-SOD expression. Using SOD2-/+ heterozygous knock-out mice, we found that Mn-SOD is a direct target of STAT3 in reperfusion-induced neuronal cell death. Our study demonstrates that STAT3 is a novel transcription factor of the mouse Mn-SOD gene and plays a crucial role as a neuroprotectant in regulating levels of reactive oxygen species in the mouse brain.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Brain / cytology
  • Brain Infarction / etiology
  • Brain Infarction / prevention & control
  • Brain Ischemia / complications
  • Brain Ischemia / prevention & control*
  • Cells, Cultured
  • Chromatin Immunoprecipitation / methods
  • Cytochromes c / metabolism
  • Disease Models, Animal
  • Electrophoretic Mobility Shift Assay / methods
  • Embryo, Mammalian
  • Glucose / deficiency
  • Humans
  • Hypoxia
  • Interleukin-6 / therapeutic use
  • Male
  • Mice
  • Mice, Knockout
  • Neurons / drug effects
  • Neuroprotective Agents / therapeutic use
  • RNA, Small Interfering / pharmacology
  • Reperfusion
  • STAT3 Transcription Factor / antagonists & inhibitors
  • STAT3 Transcription Factor / metabolism*
  • Superoxide Dismutase / deficiency
  • Superoxide Dismutase / metabolism*
  • Time Factors
  • Transfection / methods
  • Tyrphostins / therapeutic use
  • Up-Regulation / drug effects

Substances

  • Interleukin-6
  • Neuroprotective Agents
  • RNA, Small Interfering
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Cytochromes c
  • Superoxide Dismutase
  • superoxide dismutase 2
  • Glucose